{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:42:57Z","timestamp":1791664977991,"version":"4.3.4"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Oral propranolol is the first-line therapy for infantile hemangioma. Combining it with pulse dye laser (PDL) (595nm-long PDL) could reduce treatment duration and sequelae incidence and severity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To determine the effect of PDL-propranolol treatment on duration to cure and sequelae.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>All consecutive patients with infantile hemangioma who were cured by PDL-propranolol treatment were identified.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>In the 27 cases, average age at treatment start was 4.3 \u00b1 3.8 months, mean tumor diameter was 11.1 \u00b1 14.0 cm<jats:sup>2<\/jats:sup>, and tumor-type was most common (72.4% of lesions). The patients received 9.8 \u00b1 10.5 PDL sessions. After ensuring patients had no physical contraindications, including heart disease, oral propranolol was started at 1 mg\/kg\/d, increased up to 3 mg\/kg\/d as a maintenance dose. Mean propranolol treatment duration was 11.1 \u00b1 4.9 months. Total treatment duration was 15.3 \u00b1 10.8 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Our data in the context of recent literature suggest combining propranolol with PDL may reduce propranolol duration without increasing harms.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000003018","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T10:31:51Z","timestamp":1629109911000},"page":"1052-1057","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Infantile Hemangiomas Cleared by Combined Therapy With Pulsed Dye Laser and Propranolol"],"prefix":"10.1097","volume":"47","author":[{"given":"Atsuko","family":"Sugimoto","sequence":"first","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Nippon Medical School Hospital, Tokyo, Japan;"},{"name":"Greenwood Skin Clinic, Tachikawa, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsu","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Nippon Medical School Hospital, Tokyo, Japan;"},{"name":"Greenwood Skin Clinic, Tachikawa, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Toyohara","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Nippon Medical School Hospital, Tokyo, Japan;"},{"name":"Greenwood Skin Clinic, Tachikawa, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Nippon Medical School Hospital, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"e20183475","DOI":"10.1542\/peds.2018-3475","article-title":"Clinical practice guideline for the management of infantile hemangiomas","volume":"143","author":"Daniel","year":"2019","journal-title":"Pediatrics"},{"key":"R2-20250731","first-page":"657","article-title":"Combination therapy of infantile hemangioma with pulsed dye laser with topical propranolol: a randomized clinical trial","volume":"17","author":"Amir","year":"2014","journal-title":"Arch Iran Med"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00383-016-3942-x","article-title":"Effective treatment for infantile hemangioma with long-pulsed dye laser with oral propranolol medication: a preliminary report","volume":"32","author":"Shigeyuki","year":"2016","journal-title":"Pediatr Surg Int"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/09546634.2014.990412","article-title":"Topical timolol maleate 0.5% for infantile hemangioma; it's effectiveness and\/or adjunctive pulsed dye laser\u2014single center experience of 102 cases in korea","volume":"26","author":"Kyung","year":"2015","journal-title":"Dermatol Treat"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/lary.20807","article-title":"Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center","volume":"120","author":"Lisa","year":"2010","journal-title":"Laryngoscope"},{"key":"R6-20250731","first-page":"1","article-title":"Novel combination topical timolol and pulsed dye laser therapy for early effective safe treatment of infantile hemangiomas","volume":"8","author":"Chun","year":"2017","journal-title":"J Clin Exp Dermatol Res"},{"key":"R7-20250731","first-page":"92","article-title":"Combination of pulsed dye laser and propranolol in the treatment of ulcerated infantile haemangioma","volume":"84","author":"Rodr\u00edguez","year":"2016","journal-title":"AnPediatr"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/pde.12239","article-title":"Long-term treatment with oral propranolol reduces relapses of infantile hemangiomas","volume":"31","author":"Ana","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/dsu.12158","article-title":"Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser","volume":"39","author":"Kavitha","year":"2013","journal-title":"Dermatol Surg"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1542\/peds.2007-2767","article-title":"Growth characteristics of infantile hemangiomas: implications for management","volume":"122","author":"Linda","year":"2008","journal-title":"Pediatr"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/PRS.0b013e31827c6fab","article-title":"Propranolol versus corticosteroids in the treatment of infantile hemangioma: a systematic review and meta-analysis","volume":"131","author":"Ali","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1542\/peds.58.2.218","article-title":"The incidence of birthmarks in the neonate","volume":"58","author":"Alvin","year":"1976","journal-title":"Pediatr"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2133.1972.tb16188.x","article-title":"Earliest feaatures of the strawberry mark in the newborn","volume":"87","author":"Akira","year":"1972","journal-title":"Br J Dermatol"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpeds.2006.12.003","article-title":"Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics","volume":"150","author":"Anita","year":"2007","journal-title":"J Pediatr"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cps.2004.10.001","article-title":"Current management of hemangiomas and vascular malformations","volume":"32","author":"Marler","year":"2005","journal-title":"Clin Plast Surg"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/0009922806290455","article-title":"Hemangiomas: an overview","volume":"46","author":"Michael","year":"2007","journal-title":"Clin Pediatr"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jpeds.2008.05.043","article-title":"Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants","volume":"153","author":"Beth","year":"2008","journal-title":"J Pediatr"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1542\/peds.85.4.491","article-title":"Management of alarming hemangiomas Infancy\u202f: a review of 25 cases","volume":"85","author":"Odile","year":"1990","journal-title":"Pediatr"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0022-3468(83)80043-8","article-title":"Congenital vascular lesions: clinical application of a new classication","volume":"18","author":"Mary","year":"1983","journal-title":"J Pediatr Surg"},{"key":"R20-20250731","first-page":"735","article-title":"A randomized, controlled trial of oral propranolol in infantile hemangioma","volume":"372","author":"Christine","year":"2014","journal-title":"N Engl J Med"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jama.1965.03090180047011","article-title":"Cutaneous hemangiomas in children. Diagnosis and conservative management","volume":"194","author":"Margileth","year":"1965","journal-title":"JAMA"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2009.09597.x","article-title":"Propranolol for complicated infantile haemangiomas\u202f: a case series of 30 infants","volume":"162","author":"Manunza","year":"2010","journal-title":"Br J Dermatol"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1542\/peds.2012-1691","article-title":"Initiation and use of propranolol for infantile Hemangioma\u202f: report of a consensus conference abstract","volume":"131","author":"Beth","year":"2013","journal-title":"Pediatr"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1542\/peds.2006-0413","article-title":"Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment","volume":"118","author":"Anita","year":"2006","journal-title":"Pediatr"},{"key":"R25-20250731","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1525-1470.2011.01569.x","article-title":"Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome","volume":"28","author":"Christine","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/ped.12618","article-title":"Successful treatment by coil embolization for infantile hemangioma with Kasabach\u2014meritt syndrome of newborn","volume":"57","author":"Mari","year":"2015","journal-title":"Pediatr Int"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1346-8138.2010.00813.x","article-title":"Recent progress in studies of infantile hemangioma","volume":"37","author":"Masatoshi","year":"2010","journal-title":"J Dermatol"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"Christine","year":"2008","journal-title":"N Engl J Med"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/bjd.12217","article-title":"Double-blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants < 4 months of age","volume":"169","author":"Christine","year":"2013","journal-title":"Br J Dermatol"},{"key":"R30-20250731","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1172\/JCI117241","article-title":"Cellular markers that distinguish the phases of hemangioma during infancy and childhood","volume":"93","author":"Kazue","year":"1994","journal-title":"J Clin Invest"},{"key":"R31-20250731","first-page":"2592","article-title":"Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice","volume":"118","author":"Zia","year":"2008","journal-title":"J Clin Investig"},{"key":"R32-20250731","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/modpathol.3800153","article-title":"Infantile hemangiomas are arrested in an early developmental vascular differentiation state","volume":"17","author":"Soheil","year":"2004","journal-title":"Mod Pathol"},{"key":"R33-20250731","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1088\/0022-3727\/38\/15\/004","article-title":"Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm","volume":"38","author":"Bashkatov","year":"2005","journal-title":"J Phys D Appl Phys"},{"key":"R34-20250731","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/lsm.10016","article-title":"Vascular response to laser photothermolysis as a function of pulse duration, vessel type, and diameter: implications for port wine stain laser therapy","volume":"30","author":"Sol","year":"2002","journal-title":"Lasers Surg Med"},{"key":"R35-20250731","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(02)09741-6","article-title":"Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis","volume":"360","author":"Kapila","year":"2002","journal-title":"Lancet"},{"key":"R36-20250731","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3565(25)32907-1","article-title":"Contractile actions of racemic and d-propranolol on isolated canine mesenteric and coronary arteries","volume":"220","author":"Sol","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"R37-20250731","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1525-1470.2009.00975.x","article-title":"Propranolol treatment for hemangioma of Infancy\u202f: risks and recommendations","volume":"26","author":"Leslie","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"R38-20250731","doi-asserted-by":"crossref","first-page":"e1589","DOI":"10.1542\/peds.2010-0077","article-title":"Hyperkalemia complicating propranolol treatment of an infantile hemangioma","volume":"126","author":"Helena","year":"2010","journal-title":"Pediatrics"},{"key":"R39-20250731","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.vph.2010.08.002","article-title":"Propranolol suppresses angiogenesis in vitro: inhibition of proliferation, migration, and differentiation of endothelial cells","volume":"53","author":"Sylvie","year":"2010","journal-title":"Vasc Pharmacol"},{"key":"R40-20250731","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/PRS.0b013e318267d3db","article-title":"Propranolol accelerates adipogenesis in hemangioma stem cells and causes apoptosis of hemangioma endothelial cells","volume":"130","author":"Alvin","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"R41-20250731","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Napoleone","year":"2004","journal-title":"Endocr Rev"},{"key":"R42-20250731","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/SLA.0b013e318254ce7a","article-title":"Propranolol induces regression of hemangioma cells through HIF-1\u03b1\u2013mediated inhibition of VEGF-A","volume":"256","author":"Harvey","year":"2012","journal-title":"Ann Surg"},{"key":"R43-20250731","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1525-1470.2010.01224.x","article-title":"Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report","volume":"28","author":"Johannes","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"R44-20250731","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1542\/peds.2010-0029","article-title":"A randomized controlled trial of Propranolol for infantile haemangiomas","volume":"128","author":"Marcia","year":"2011","journal-title":"Pediatr"},{"key":"R45-20250731","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/bjd.12127","article-title":"Propranolol induces apoptosis of human umbilical vein endothelial cells through downregulation of CD147","volume":"168","author":"Xie","year":"2013","journal-title":"Br J Dermatol"},{"key":"R46-20250731","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.jpedsurg.2012.09.008","article-title":"Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells","volume":"47","author":"Yi","year":"2012","journal-title":"J Pediatr Surg"},{"key":"R47-20250731","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jpeds.2013.03.080","article-title":"Consensus derived practice standards plan for complicated Kaposiform hemangioendothelioma","volume":"163","author":"Beth","year":"2013","journal-title":"J Pediatr"},{"key":"R48-20250731","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","article-title":"Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action","volume":"163","author":"Storch","year":"2010","journal-title":"Br J Dermatol"},{"key":"R49-20250731","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1542\/peds.2008-3458","article-title":"Propranolol for severe infantile hemangiomas: follow-up report","volume":"124","author":"Veronique","year":"2009","journal-title":"Pediatr"},{"key":"R50-20250731","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bjps.2010.07.009","article-title":"Propranolol as first-line treatment for rapidly proliferating Infantile Hemangiomas","volume":"64","author":"Holmes","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R51-20250731","first-page":"114","article-title":"Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser. Dermatol surg. 2013;39:923\u201333. Treatment with oral propranolol reduces relapses of infantile hemangiomas","volume":"31","author":"Kavitha","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"R52-20250731","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archderm.1960.01580050009002","article-title":"The natural history of the strawberry nevus","volume":"82","author":"Bowers","year":"1960","journal-title":"Arch Dermatol"},{"key":"R53-20250731","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jamadermatol.2016.2905","article-title":"Risk factors for degree and type of sequelae after involution of untreated hemangiomas of infancy","volume":"152","author":"Eulalia","year":"2016","journal-title":"JAMA Dermatol"},{"key":"R54-20250731","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/PRS.0b013e318208d2ac","article-title":"Untreated hemangiomas: growth pattern and residual lesions","volume":"127","author":"Constantijn","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"R55-20250731","first-page":"9","article-title":"Simple and easy surgical technique for infantile Hemangiomas\u202f: intralesional excision and primary","volume":"15","author":"Tadashi","year":"2015","journal-title":"ePlasty"},{"key":"R56-20250731","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ijporl.2007.04.004","article-title":"Circular excision and purse-string suture technique in the management of facial hemangiomas","volume":"71","author":"Aleksandar","year":"2007","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R57-20250731","first-page":"1","article-title":"Surgical management of vascular anomalies in children at a tertiary care hospital in a resource limited setting: a Tanzanian experience with 134 patients","volume":"8","author":"Phillipo","year":"2015","journal-title":"BMC Res Notes"},{"key":"R58-20250731","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1524-4725.2012.02487.x","article-title":"Beneficial effects of early pulsed dye laser therapy in individuals with infantile hemangiomas","volume":"38","author":"Shehla","year":"2012","journal-title":"Dermatol Surg"},{"key":"R59-20250731","first-page":"112","article-title":"Comparison study of a traditional pulsed dye laser versus a long-pulsed dye laser in the treatment of early childhood hemangiomas","volume":"38","author":"Taro","year":"2005","journal-title":"Lasers Surg Med"},{"key":"R60-20250731","first-page":"1","article-title":"When to stop propranolol for infantile hemangioma","volume":"7","author":"Lei","year":"2017","journal-title":"Sci Rep"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:14:03Z","timestamp":1754000043000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000003018","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}